Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 41  Show
  1. 1
    "cDNA cloning of a G-protein-coupled receptor expressed in rat spinal cord and brain related to chemokine receptors."
    Harrison J.K., Barber C.M., Lynch K.R.
    Neurosci. Lett. 169:85-89(1994) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, ABSENCE OF GLYCOSYLATION.
    Category: PTM / Processing, Expression, Sequences.
    Strain: Sprague-Dawley.
    Tissue: Spinal cord.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    "Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia."
    Boddeke E.W., Meigel I., Frentzel S., Biber K., Renn L.Q., Gebicke-Harter P.
    Eur. J. Pharmacol. 374:309-313(1999) [PubMed] [Europe PMC] [Abstract]
    Category: Expression.
    Source: RGD:620137.
  3. 3
    "Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication."
    Feng L., Chen S., Garcia G.E., Xia Y., Siani M.A., Botti P., Wilson C.B., Harrison J.K., Bacon K.B.
    Kidney Int. 56:612-620(1999) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.
  4. 4
    "Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival."
    Meucci O., Fatatis A., Simen A.A., Miller R.J.
    Proc. Natl. Acad. Sci. U.S.A. 97:8075-8080(2000) [PubMed] [Europe PMC] [Abstract]
    Category: Subcellular Location.
    Source: RGD:620137.
  5. 5
    "Mutational analysis of the fractalkine chemokine domain. Basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion."
    Harrison J.K., Fong A.M., Swain P.A., Chen S., Yu Y.R., Salafranca M.N., Greenleaf W.B., Imai T., Patel D.D.
    J. Biol. Chem. 276:21632-21641(2001) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Source: RGD:620137.
  6. 6
    "Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis."
    Ruth J.H., Volin M.V., Haines G.K., Woodruff D.C., Katschke K.J. Jr., Woods J.M., Park C.C., Morel J.C., Koch A.E.
    Arthritis Rheum. 44:1568-1581(2001) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  7. 7
    "Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS."
    Hughes P.M., Botham M.S., Frentzel S., Mir A., Perry V.H.
    Glia 37:314-327(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Subcellular Location, Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 5 other entries.

  8. 8
    "Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis."
    Ito Y., Kawachi H., Morioka Y., Nakatsue T., Koike H., Ikezumi Y., Oyanagi A., Natori Y., Natori Y., Nakamura T., Gejyo F., Shimizu F.
    Kidney Int. 61:2044-2057(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  9. 9
    "Upregulation of chemokine receptor gene expression in brains of Borna disease virus (BDV)-infected rats in the absence and presence of inflammation."
    Rauer M., Pagenstecher A., Schulte-Monting J., Sauder C.
    J. Neurovirol. 8:168-179(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  10. 10
    "TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia."
    Chen S., Luo D., Streit W.J., Harrison J.K.
    J. Neuroimmunol. 133:46-55(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Expression.
    Source: RGD:620137.
  11. 11
    "Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats."
    Chen Y.M., Hu-Tsai M.I., Lin S.L., Tsai T.J., Hsieh B.S.
    Nephrol. Dial. Transplant. 18:2505-2514(2003) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  12. 12
    "Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys."
    Kikuchi Y., Ikee R., Hemmi N., Hyodo N., Saigusa T., Namikoshi T., Yamada M., Suzuki S., Miura S.
    Nephron Exp. Nephrol. 97:e17-25(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  13. 13
    "Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions."
    Verge G.M., Milligan E.D., Maier S.F., Watkins L.R., Naeve G.S., Foster A.C.
    Eur. J. Neurosci. 20:1150-1160(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.
  14. 14
    "Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis."
    Fang I.M., Lin C.P., Yang C.M., Chen M.S., Yang C.H.
    Mol. Vis. 11:443-451(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  15. 15
    "CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin."
    Sunnemark D., Eltayeb S., Nilsson M., Wallstrom E., Lassmann H., Olsson T., Berg A.L., Ericsson-Dahlstrand A.
    J Neuroinflammation 2:17-17(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  16. 16
    "An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine."
    Milligan E., Zapata V., Schoeniger D., Chacur M., Green P., Poole S., Martin D., Maier S.F., Watkins L.R.
    Eur. J. Neurosci. 22:2775-2782(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.
  17. 17
    "Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis."
    Yuridullah R., Corrow K.A., Malley S.E., Vizzard M.A.
    Auton Neurosci 126-127:380-389(2006) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  18. 18
    "The chemokine CX3CL1 reduces migration and increases adhesion of neurons with mechanisms dependent on the beta1 integrin subunit."
    Lauro C., Catalano M., Trettel F., Mainiero F., Ciotti M.T., Eusebi F., Limatola C.
    J. Immunol. 177:7599-7606(2006) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  19. 19
    "New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis."
    Sun S., Cao H., Han M., Li T.T., Pan H.L., Zhao Z.Q., Zhang Y.Q.
    Pain 129:64-75(2007) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.
  20. 20
    "Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension."
    Perros F., Dorfmuller P., Souza R., Durand-Gasselin I., Godot V., Capel F., Adnot S., Eddahibi S., Mazmanian M., Fadel E., Herve P., Simonneau G., Emilie D., Humbert M.
    Eur. Respir. J. 29:937-943(2007) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  21. 21
    "Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia."
    Ryu J., Lee C.W., Hong K.H., Shin J.A., Lim S.H., Park C.S., Shim J., Nam K.B., Choi K.J., Kim Y.H., Han K.H.
    Cardiovasc. Res. 78:333-340(2008) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Source: RGD:620137.

    This publication is mapped to 53 other entries.

  22. 22
    "Spinal changes associated with mechanical hypersensitivity in a model of Guillain-Barre syndrome."
    Luongo L., Sajic M., Grist J., Clark A.K., Maione S., Malcangio M.
    Neurosci. Lett. 437:98-102(2008) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  23. 23
    "New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease."
    Shan S., Hong-Min T., Yi F., Jun-Peng G., Yue F., Yan-Hong T., Yun-Ke Y., Wen-Wei L., Xiang-Yu W., Jun M., Guo-Hua W., Ya-Ling H., Hua-Wei L., Ding-Fang C.
    Neurobiol. Aging 32:443-458(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  24. 24
    "Expression of the chemokine fractalkine (FKN/CX3CL1) by podocytes in normal and proteinuric rat kidney glomerulus."
    Katsuyama K., Fujinaka H., Yamamoto K., Nameta M., Yaoita E., Yoshida Y., Tomizawa S., Uchiyama M., Yamamoto T.
    Nephron Exp. Nephrol. 113:e45-56(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

  25. 25
    "Expression of fractalkine (CX3CL1) and its receptor in endotoxin-induced uveitis."
    Chu L., Li X., Yu W., Qian T., Qi H., Huang L., Xu Y.
    Ophthalmic Res. 42:160-166(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Source: RGD:620137.

    This publication is mapped to 2 other entries.

1 to 25 of 41  Show

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health